CHESTERFIELD, Mo., Aug. 23 /PRNewswire-FirstCall/ -- Reliv
International, Inc., (Nasdaq: RELV), a developer, manufacturer and marketer
of proprietary nutritional supplements, today said it has resumed activity
in its share repurchase program.
In announcing the resumption, Robert L. Montgomery, chairman, president
and CEO of Reliv, stated, "Current market conditions have made repurchase
by Reliv of its common stock an attractive use of funds at this time."
In March 2005, the Board of Directors approved a share repurchase plan
of up to $15 million over the next 36 months. To date, Reliv has purchased
433,000 shares of common stock under the plan and had approximately $10.7
million still available.
About Reliv
Reliv International, Inc., based in suburban St. Louis, Mo., develops,
manufactures and markets a proprietary line of nutritional supplements
addressing basic nutrition, specific wellness needs, weight management and
sports nutrition. Reliv sells its products through an international network
marketing system of approximately 65,000 independent distributors. Reliv
International's common stock trades on The Nasdaq Stock Market(R) under the
symbol RELV. Additional information about Reliv International, Inc. can be
obtained on the Web at http://www.reliv.com.
Statements made in this release that are not historical facts are
"forward-looking" statements (as defined in the Private Securities
Litigation Reform Act of 1995) that involve risks and uncertainties and are
subject to change at any time. These forward-looking statements may
include, but are not limited to, statements containing words such as "may,"
"should," "could," "would," "expect," "plan," "anticipate," "believe,"
"estimate," "predict," "potential," "continue," or similar expressions.
SOURCE Reliv International, Inc.
 back to top
Related links:
http://www.reliv.com/
http://www.prnewswire.com/comp/103123.html /
CONTACT:
Steven D. Albright, Chief Financial Officer,
+1-636-733-1305, or Fred A. Nielson, Investor Relations,
+1-636-733-1314, both of Reliv
|
